Allen, R. P., Bharmal, M. & Calloway, M. Prevalence and disease burden of primary restless legs syndrome: results of a general population survey in the United States. Mov. Disord. 26, 114–120. https://doi.org/10.1002/mds.23430 (2011).
Allen, R. P. et al. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria–history, rationale, description, and significance. Sleep. Med. 15, 860–873. https://doi.org/10.1016/j.sleep.2014.03.025 (2014).
Earley, C. J., Uhl, G. R., Clemens, S. & Ferre, S. Connectome and molecular pharmacological differences in the dopaminergic system in restless legs syndrome (RLS): plastic changes and neuroadaptations that may contribute to augmentation. Sleep. Med. 31, 71–77. https://doi.org/10.1016/j.sleep.2016.06.003 (2017).
Schormair, B. et al. Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis. Lancet Neurol. 16, 898–907. https://doi.org/10.1016/S1474-4422(17)30327-7 (2017).
Schormair Genome-wide meta-analyses of restless legs syndrome yield insights into genetic architecture, disease biology, and risk prediction. Nat. Genet. (2024).
Cotney, J. et al. The autism-associated chromatin modifier CHD8 regulates other autism risk genes during human neurodevelopment. Nat. Commun. 6, 6404. https://doi.org/10.1038/ncomms7404 (2015).
Duboule, D. The rise and fall of hox gene clusters. Development 134, 2549–2560. https://doi.org/10.1242/dev.001065 (2007).
Spieler, D. et al. Restless legs syndrome-associated intronic common variant in Meis1 alters enhancer function in the developing telencephalon. Genome Res. 24, 592–603. https://doi.org/10.1101/gr.166751.113 (2014).
Winkelmann, J. et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat. Genet. 39, 1000–1006. https://doi.org/10.1038/ng2099 (2007).
Lam, D. D. et al. Intronic elements associated with insomnia and restless legs syndrome exhibit cell-type-specific epigenetic features contributing to MEIS1 regulation. Hum. Mol. Genet. 31, 1733–1746. https://doi.org/10.1093/hmg/ddab355 (2022).
Xiong, L. et al. MEIS1 intronic risk haplotype associated with restless legs syndrome affects its mRNA and protein expression levels. Hum. Mol. Genet. 18, 1065–1074. https://doi.org/10.1093/hmg/ddn443 (2009).
Sarayloo, F. et al. Mineral absorption is an enriched pathway in a brain region of restless legs syndrome patients with reduced MEIS1 expression. PLoS One. 14, e0225186. https://doi.org/10.1371/journal.pone.0225186 (2019).
Moskow, J. J., Bullrich, F., Huebner, K., Daar, I. O. & Buchberg, A. M. Meis1, a PBX1-related homeobox gene involved in myeloid leukemia in BXH-2 mice. Mol. Cell. Biol. 15, 5434–5443. https://doi.org/10.1128/mcb.15.10.5434 (1995).
Dupacova, N., Antosova, B., Paces, J. & Kozmik, Z. Meis homeobox genes control progenitor competence in the retina. Proc. Natl. Acad. Sci. U S A. 118 https://doi.org/10.1073/pnas.2013136118 (2021).
Argiropoulos, B., Yung, E. & Humphries, R. K. Unraveling the crucial roles of Meis1 in leukemogenesis and normal hematopoiesis. Genes Dev. 21, 2845–2849. https://doi.org/10.1101/gad.1619407 (2007).
Azcoitia, V., Aracil, M., Martinez, A. C. & Torres, M. The homeodomain protein Meis1 is essential for definitive hematopoiesis and vascular patterning in the mouse embryo. Dev. Biol. 280, 307–320. https://doi.org/10.1016/j.ydbio.2005.01.004 (2005).
Delgado, I. et al. Control of mouse limb initiation and antero-posterior patterning by Meis transcription factors. Nat. Commun. 12, 3086. https://doi.org/10.1038/s41467-021-23373-9 (2021).
Delgado, I. et al. Proximo-distal positional information encoded by an fgf-regulated gradient of homeodomain transcription factors in the vertebrate limb. Sci. Adv. 6, eaaz0742. https://doi.org/10.1126/sciadv.aaz0742 (2020).
Mahmoud, A. I. et al. Meis1 regulates postnatal cardiomyocyte cell cycle arrest. Nature 497, 249–253. https://doi.org/10.1038/nature12054 (2013).
Marcos, S. et al. Meis1 coordinates a network of genes implicated in eye development and microphthalmia. Development 142, 3009–. https://doi.org/10.1242/dev.122176 (2015).
Agoston, Z. et al. Meis2 is a Pax6 co-factor in neurogenesis and dopaminergic periglomerular fate specification in the adult olfactory bulb. Development 141, 28–38. https://doi.org/10.1242/dev.097295 (2014).
Agoston, Z., Li, N., Haslinger, A., Wizenmann, A. & Schulte, D. Genetic and physical interaction of Meis2, Pax3 and Pax7 during dorsal midbrain development. BMC Dev. Biol. 12, 10. https://doi.org/10.1186/1471-213X-12-10 (2012).
Agoston, Z. & Schulte, D. Meis2 competes with the Groucho co-repressor Tle4 for binding to Otx2 and specifies tectal fate without induction of a secondary midbrain-hindbrain boundary organizer. Development 136, 3311–3322. https://doi.org/10.1242/dev.037770 (2009).
Bouilloux, F. et al. Loss of the transcription factor Meis1 prevents sympathetic neurons target-field innervation and increases susceptibility to sudden cardiac death. Elife 5 https://doi.org/10.7554/eLife.11627 (2016).
Lepko, T. et al. Choroid plexus-derived miR-204 regulates the number of quiescent neural stem cells in the adult brain. EMBO J. 38, e100481. https://doi.org/10.15252/embj.2018100481 (2019).
Barber, B. A. et al. Dynamic expression of MEIS1 homeoprotein in E14.5 forebrain and differentiated forebrain-derived neural stem cells. Ann. Anat. 195, 431–440. https://doi.org/10.1016/j.aanat.2013.04.005 (2013).
Lopez-Delgado, A. C., Delgado, I., Cadenas, V., Sanchez-Cabo, F. & Torres, M. Axial skeleton anterior-posterior patterning is regulated through feedback regulation between Meis transcription factors and retinoic acid. Development 148 https://doi.org/10.1242/dev.193813 (2021).
Lai, C. K. et al. Meis2 as a critical player in MN1-induced leukemia. Blood Cancer J. 7, e613. https://doi.org/10.1038/bcj.2017.86 (2017).
Machon, O., Masek, J., Machonova, O., Krauss, S. & Kozmik, Z. Meis2 is essential for cranial and cardiac neural crest development. BMC Dev. Biol. 15, 40. https://doi.org/10.1186/s12861-015-0093-6 (2015).
Bhanvadia, R. R. et al. MEIS1 and MEIS2 expression and prostate Cancer progression: a role for HOXB13 binding partners in metastatic disease. Clin. Cancer Res. 24, 3668–3680. https://doi.org/10.1158/1078-0432.CCR-17-3673 (2018).
Geerts, D., Schilderink, N., Jorritsma, G. & Versteeg, R. The role of the MEIS homeobox genes in neuroblastoma. Cancer Lett. 197, 87–92. https://doi.org/10.1016/s0304-3835(03)00087-9 (2003).
Melvin, V. S., Feng, W., Hernandez-Lagunas, L., Artinger, K. B. & Williams, T. A morpholino-based screen to identify novel genes involved in craniofacial morphogenesis. Dev. Dyn. 242, 817–831. https://doi.org/10.1002/dvdy.23969 (2013).
Oulad-Abdelghani, M. et al. Meis2, a novel mouse pbx-related homeobox gene induced by retinoic acid during differentiation of P19 embryonal carcinoma cells. Dev. Dyn. 210, 173–183. https://doi.org/10.1002/(SICI)1097-0177(199710)210:2<173::AID-AJA9>3.0.CO:2-D (1997).
Toresson, H., Parmar, M. & Campbell, K. Expression of Meis and pbx genes and their protein products in the developing telencephalon: implications for regional differentiation. Mech. Dev. 94, 183–187 (2000).
Jinek, M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816–821. https://doi.org/10.1126/science.1225829 (2012).
Konermann, S. et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature 517, 583–588. https://doi.org/10.1038/nature14136 (2015).
Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods. 11, 783–784. https://doi.org/10.1038/nmeth.3047 (2014).
Love, M. I., Huber, W. & Anders, S. Moderated estimation of Fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550. https://doi.org/10.1186/s13059-014-0550-8 (2014).
Concordet, J. P. & Haeussler, M. CRISPOR: intuitive guide selection for CRISPR/Cas9 genome editing experiments and screens. Nucleic Acids Res. 46, W242–W245. https://doi.org/10.1093/nar/gky354 (2018).
Becht, E. et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat. Biotechnol. https://doi.org/10.1038/nbt.4314 (2018).
Yang, Y. et al. Dimensionality reduction by UMAP reinforces sample heterogeneity analysis in bulk transcriptomic data. Cell. Rep. 36, 109442. https://doi.org/10.1016/j.celrep.2021.109442 (2021).
Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25–29. https://doi.org/10.1038/75556 (2000).
Consortium, G. O. et al. The Gene Ontology knowledgebase in 2023. Genetics 224 https://doi.org/10.1093/genetics/iyad031 (2023).
Calipari, E. S. & Ferris, M. J. Amphetamine mechanisms and actions at the dopamine terminal revisited. J. Neurosci. 33, 8923–8925. https://doi.org/10.1523/JNEUROSCI.1033-13.2013 (2013).
Fienberg, A. A. et al. DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science 281, 838–842. https://doi.org/10.1126/science.281.5378.838 (1998).
Toresson, H., Mata de Urquiza, A., Fagerstrom, C., Perlmann, T. & Campbell, K. Retinoids are produced by glia in the lateral ganglionic eminence and regulate striatal neuron differentiation. Development 126, 1317–1326 (1999).
Pfeufer, A. et al. Genome-wide association study of PR interval. Nat. Genet. 42, 153–159. https://doi.org/10.1038/ng.517 (2010).
Penkov, D. et al. Analysis of the DNA-Binding Profile and function of TALE homeoproteins reveals their specialization and specific interactions with hox Genes/Proteins. Cell. Rep. 3, 1321–1333. https://doi.org/10.1016/j.celrep.2013.03.029 (2013).
Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell. 38, 576–589. https://doi.org/10.1016/j.molcel.2010.05.004 (2010).
Svingen, T. & Tonissen, K. F. Hox transcription factors and their elusive mammalian gene targets. Heredity (Edinb). 97, 88–96. https://doi.org/10.1038/sj.hdy.6800847 (2006).
Ronzio, M., Zambelli, F., Dolfini, D., Mantovani, R. & Pavesi, G. Integrating peak colocalization and Motif Enrichment Analysis for the Discovery of Genome-Wide Regulatory Modules and transcription factor recruitment rules. Front. Genet. 11, 72. https://doi.org/10.3389/fgene.2020.00072 (2020).
Volkel, S. et al. Transcription factor Sp2 potentiates binding of the TALE homeoproteins Pbx1:Prep1 and the histone-fold domain protein Nf-y to composite genomic sites. J. Biol. Chem. 293, 19250–19262. https://doi.org/10.1074/jbc.RA118.005341 (2018).
Longobardi, E. et al. Prep1 (pKnox1)-deficiency leads to spontaneous tumor development in mice and accelerates EmuMyc lymphomagenesis: a tumor suppressor role for Prep1. Mol. Oncol. 4, 126–134. https://doi.org/10.1016/j.molonc.2010.01.001 (2010).
Ferri, A. et al. Sox2 is required for embryonic development of the ventral telencephalon through the activation of the ventral determinants Nkx2.1 and shh. Development 140, 1250–1261. https://doi.org/10.1242/dev.073411 (2013).
Lefebvre, V., Dumitriu, B., Penzo-Mendez, A., Han, Y. & Pallavi, B. Control of cell fate and differentiation by sry-related high-mobility-group box (Sox) transcription factors. Int. J. Biochem. Cell. Biol. 39, 2195–2214. https://doi.org/10.1016/j.biocel.2007.05.019 (2007).
Wang, S. et al. Target analysis by integration of transcriptome and ChIP-seq data with BETA. Nat. Protoc. 8, 2502–2515. https://doi.org/10.1038/nprot.2013.150 (2013).
Catoire, H. et al. A direct interaction between two restless legs syndrome predisposing genes: MEIS1 and SKOR1. Sci. Rep. 8, 12173. https://doi.org/10.1038/s41598-018-30665-6 (2018).
Salminen, A. V., Schandra, N., Schormair, B., Oexle, K. & Winkelmann, J. Therapeutic effectiveness of thalidomide in a patient with treatment-resistant restless legs syndrome. J. Clin. Sleep. Med. 16, 1815–1817. https://doi.org/10.5664/jcsm.8696 (2020).
Fishilevich, S. et al. GeneHancer: genome-wide integration of enhancers and target genes in GeneCards. Database (Oxford). 2017 https://doi.org/10.1093/database/bax028 (2017).
Yan, P. et al. Genome-wide R-loop landscapes during cell differentiation and reprogramming. Cell. Rep. 32, 107870. https://doi.org/10.1016/j.celrep.2020.107870 (2020).
Zou, Z., Ohta, T., Oki, S. & ChIP-Atlas 3.0: a data-mining suite to explore chromosome architecture together with large-scale regulome data. Nucleic Acids Res. 52, W45–W53. https://doi.org/10.1093/nar/gkae358 (2024).
Antosova, B. et al. The Gene Regulatory Network of Lens Induction is Wired through Meis-Dependent Shadow enhancers of Pax6. PLoS Genet. 12, e1006441. https://doi.org/10.1371/journal.pgen.1006441 (2016).
Longobardi, E. et al. Biochemistry of the tale transcription factors PREP, MEIS, and PBX in vertebrates. Dev. Dyn. 243, 59–75. https://doi.org/10.1002/dvdy.24016 (2014).
Bridoux, L. et al. HOX paralogs selectively convert binding of ubiquitous transcription factors into tissue-specific patterns of enhancer activation. PLoS Genet. 16, e1009162. https://doi.org/10.1371/journal.pgen.1009162 (2020).
Feng, S. et al. Transcription factor paralogs orchestrate alternative gene regulatory networks by context-dependent cooperation with multiple cofactors. Nat. Commun. 13, 3808. https://doi.org/10.1038/s41467-022-31501-2 (2022).
Slattery, M. et al. Cofactor binding evokes latent differences in DNA binding specificity between hox proteins. Cell 147, 1270–1282. https://doi.org/10.1016/j.cell.2011.10.053 (2011).
Chang, C. P. et al. Meis proteins are major in vivo DNA binding partners for wild-type but not chimeric pbx proteins. Mol. Cell. Biol. 17, 5679–5687 (1997).
Berthelsen, J., Kilstrup-Nielsen, C., Blasi, F., Mavilio, F. & Zappavigna, V. The subcellular localization of PBX1 and EXD proteins depends on nuclear import and export signals and is modulated by association with PREP1 and HTH. Genes Dev. 13, 946–953. https://doi.org/10.1101/gad.13.8.946 (1999).
Ferretti, E. et al. Segmental expression of Hoxb2 in r4 requires two separate sites that integrate cooperative interactions between Prep1, pbx and hox proteins. Development 127, 155–166 (2000).
Knoepfler, P. S., Calvo, K. R., Chen, H., Antonarakis, S. E. & Kamps, M. P. Meis1 and pKnox1 bind DNA cooperatively with Pbx1 utilizing an interaction surface disrupted in oncoprotein E2a-Pbx1. Proc. Natl. Acad. Sci. U S A. 94, 14553–14558. https://doi.org/10.1073/pnas.94.26.14553 (1997).
Shen, W. F. et al. AbdB-like hox proteins stabilize DNA binding by the Meis1 homeodomain proteins. Mol. Cell. Biol. 17, 6448–6458. https://doi.org/10.1128/mcb.17.11.6448 (1997).
Shanmugam, K., Green, N. C., Rambaldi, I., Saragovi, H. U. & Featherstone, M. S. PBX and MEIS as non-DNA-binding partners in trimeric complexes with HOX proteins. Mol. Cell. Biol. 19, 7577–7588. https://doi.org/10.1128/mcb.19.11.7577 (1999).
Bisaillon, R., Wilhelm, B. T., Krosl, J. & Sauvageau, G. C-terminal domain of MEIS1 converts PKNOX1 (PREP1) into a HOXA9-collaborating oncoprotein. Blood 118, 4682–4689. https://doi.org/10.1182/blood-2011-05-354076 (2011).
Huang, H. et al. MEIS C termini harbor transcriptional activation domains that respond to cell signaling. J. Biol. Chem. 280, 10119–10127. https://doi.org/10.1074/jbc.M413963200 (2005).
Hyman-Walsh, C., Bjerke, G. A. & Wotton, D. An autoinhibitory effect of the homothorax domain of Meis2. FEBS J. 277, 2584–2597. https://doi.org/10.1111/j.1742-464X.2010.07668.x (2010).
Williams, T. M., Williams, M. E. & Innis, J. W. Range of HOX/TALE superclass associations and protein domain requirements for HOXA13:MEIS interaction. Dev. Biol. 277, 457–471. https://doi.org/10.1016/j.ydbio.2004.10.004 (2005).
Gera, T., Jonas, F., More, R. & Barkai, N. Evolution of binding preferences among whole-genome duplicated transcription factors. Elife 11 https://doi.org/10.7554/eLife.73225 (2022).
Mukherjee, K. & Burglin, T. R. Comprehensive analysis of animal TALE homeobox genes: new conserved motifs and cases of accelerated evolution. J. Mol. Evol. 65, 137–153. https://doi.org/10.1007/s00239-006-0023-0 (2007).
Zhang, Y., Ho, T. D., Buchler, N. E. & Gordan, R. Competition for DNA binding between paralogous transcription factors determines their genomic occupancy and regulatory functions. Genome Res. 31, 1216–1229. https://doi.org/10.1101/gr.275145.120 (2021).
Majidi, S. P. et al. Chromatin Environment and Cellular Context Specify Compensatory activity of paralogous MEF2 transcription factors. Cell. Rep. 29, 2001–2015. https://doi.org/10.1016/j.celrep.2019.10.033 (2019). e2005.
Shen, N. et al. Divergence in DNA specificity among Paralogous Transcription Factors Contributes to their Differential in vivo binding. Cell. Syst. 6, 470–483. https://doi.org/10.1016/j.cels.2018.02.009 (2018). e478.
Gurska, D., Vargas Jentzsch, I. M. & Panfilio, K. A. Unexpected mutual regulation underlies paralogue functional diversification and promotes epithelial tissue maturation in Tribolium. Commun. Biol. 3, 552. https://doi.org/10.1038/s42003-020-01250-3 (2020).
Destain, H., Prahlad, M. & Kratsios, P. Maintenance of neuronal identity in C. Elegans and beyond: lessons from transcription and chromatin factors. Semin Cell. Dev. Biol. 154, 35–47. https://doi.org/10.1016/j.semcdb.2023.07.001 (2024).
Leyva-Diaz, E. & Hobert, O. Transcription factor autoregulation is required for acquisition and maintenance of neuronal identity. Development 146 https://doi.org/10.1242/dev.177378 (2019).
Adamaki, M. et al. HOXA9 and MEIS1 gene overexpression in the diagnosis of childhood acute leukemias: significant correlation with relapse and overall survival. Leuk. Res. 39, 874–882. https://doi.org/10.1016/j.leukres.2015.04.012 (2015).
Wang, Q. F. et al. Regulation of MEIS1 by distal enhancer elements in acute leukemia. Leukemia 28, 138–146. https://doi.org/10.1038/leu.2013.260 (2014).
El-Brolosy, M. A. et al. Genetic compensation triggered by mutant mRNA degradation. Nature 568, 193–197. https://doi.org/10.1038/s41586-019-1064-z (2019).
Ma, Z. & Chen, J. Premature termination Codon-Bearing mRNA mediates genetic compensation response. Zebrafish https://doi.org/10.1089/zeb.2019.1824 (2020).
Xie, A. et al. Upf3a but not Upf1 mediates the genetic compensation response induced by leg1 deleterious mutations in an H3K4me3-independent manner. Cell. Discov. 9, 63. https://doi.org/10.1038/s41421-023-00550-2 (2023).
Graham, V., Khudyakov, J., Ellis, P. & Pevny, L. SOX2 functions to maintain neural progenitor identity. Neuron 39, 749–765. https://doi.org/10.1016/s0896-6273(03)00497-5 (2003).
Yun, K., Garel, S., Fischman, S. & Rubenstein, J. L. Patterning of the lateral ganglionic eminence by the Gsh1 and Gsh2 homeobox genes regulates striatal and olfactory bulb histogenesis and the growth of axons through the basal ganglia. J. Comp. Neurol. 461, 151–165. https://doi.org/10.1002/cne.10685 (2003).
Bacon, C. et al. Brain-specific Foxp1 deletion impairs neuronal development and causes autistic-like behaviour. Mol. Psychiatry. 20, 632–639. https://doi.org/10.1038/mp.2014.116 (2015).
Murugan, M., Harward, S., Scharff, C. & Mooney, R. Diminished FoxP2 levels affect dopaminergic modulation of corticostriatal signaling important to song variability. Neuron 80, 1464–1476. https://doi.org/10.1016/j.neuron.2013.09.021 (2013).
Precious, S. V. et al. FoxP1 marks medium spiny neurons from precursors to maturity and is required for their differentiation. Exp. Neurol. 282, 9–18. https://doi.org/10.1016/j.expneurol.2016.05.002 (2016).
van Rhijn, J. R., Fisher, S. E. & Vernes, S. C. Nadif Kasri, N. Foxp2 loss of function increases striatal direct pathway inhibition via increased GABA release. Brain Struct. Funct. 223, 4211–4226. https://doi.org/10.1007/s00429-018-1746-6 (2018).
Michaud, M., Lavigne, G., Desautels, A., Poirier, G. & Montplaisir, J. Effects of immobility on sensory and motor symptoms of restless legs syndrome. Mov. Disord. 17, 112–115. https://doi.org/10.1002/mds.10004 (2002).
Earley, C. J. et al. Increased synaptic dopamine in the putamen in restless legs syndrome. Sleep 36, 51–57. https://doi.org/10.5665/sleep.2300 (2013).
Kocar, T. D., Muller, H. P. & Kassubek, J. Differential functional connectivity in thalamic and dopaminergic pathways in restless legs syndrome: a meta-analysis. Ther. Adv. Neurol. Disord. 13, 1756286420941670. https://doi.org/10.1177/1756286420941670 (2020).
Salminen, A. V. et al. Consensus guidelines on Rodent models of restless legs syndrome. Mov. Disord. 36, 558–569. https://doi.org/10.1002/mds.28401 (2021).
Earley, C. J., Jones, B. C. & Ferre, S. Brain-iron deficiency models of restless legs syndrome. Exp. Neurol. 356, 114158. https://doi.org/10.1016/j.expneurol.2022.114158 (2022).
Nishi, A., Snyder, G. L. & Greengard, P. Bidirectional regulation of DARPP-32 phosphorylation by dopamine. J. Neurosci. 17, 8147–8155. https://doi.org/10.1523/JNEUROSCI.17-21-08147.1997 (1997).
Ouimet, C., Miller, P., Hemmings, H. C., Walaas, J., Greengard, P. & S. & DARPP-32, a dopamine- and adenosine 3’:5’-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization. J. Neurosci. 4, 111–124. https://doi.org/10.1523/jneurosci.04-01-00111.1984 (1984).
Bateup, H. S. et al. Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors. Proc. Natl. Acad. Sci. U S A. 107, 14845–14850. https://doi.org/10.1073/pnas.1009874107 (2010).
Su, Z. et al. Dlx1/2-dependent expression of Meis2 promotes neuronal fate determination in the mammalian striatum. Development 149 https://doi.org/10.1242/dev.200035 (2022).
Dvoretskova, E. et al. Spatial enhancer activation influences inhibitory neuron identity during mouse embryonic development. Nat. Neurosci. https://doi.org/10.1038/s41593-024-01611-9 (2024).
Yang, L. et al. Transcriptional Profiling Reveals the Transcription Factor Networks Regulating the Survival of Striatal Neurons. bioRxiv (2021).
Cathiard, L. et al. Investigation of dopaminergic signalling in Meis homeobox 1 (Meis1) deficient mice as an animal model of restless legs syndrome. J Sleep Res, e13311 (2021). https://doi.org/10.1111/jsr.13311
Ferre, S. et al. Pivotal role of Adenosine neurotransmission in restless legs syndrome. Front. Neurosci. 11, 722. https://doi.org/10.3389/fnins.2017.00722 (2017).
Lanza, G. et al. Impaired short-term plasticity in restless legs syndrome: a pilot rTMS study. Sleep. Med. 46, 1–4. https://doi.org/10.1016/j.sleep.2018.02.008 (2018).
Castiglioni, V. et al. Dynamic and cell-specific DACH1 expression in human neocortical and Striatal Development. Cereb. Cortex. 29, 2115–2124. https://doi.org/10.1093/cercor/bhy092 (2019).
Gangwar, S. P. et al. Molecular Mechanism of MDGA1: Regulation of Neuroligin 2:Neurexin Trans-synaptic Bridges. Neuron 94, 1132–1141 e1134 (2017). https://doi.org/10.1016/j.neuron.2017.06.009
Matsukawa, H. et al. Netrin-G/NGL complexes encode functional synaptic diversification. J. Neurosci. 34, 15779–15792. https://doi.org/10.1523/JNEUROSCI.1141-14.2014 (2014).
Sarayloo, F., Dion, P. A. & Rouleau, G. A. MEIS1 and restless legs syndrome: a Comprehensive Review. Front. Neurol. 10, 935. https://doi.org/10.3389/fneur.2019.00935 (2019).
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21. https://doi.org/10.1093/bioinformatics/bts635 (2013).
Anders, S., Pyl, P. T. & Huber, W. HTSeq–a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166–169. https://doi.org/10.1093/bioinformatics/btu638 (2015).
Davison, A. C. & Hinkley, D. V. in Bootstrap Methods and their Application Ch. 5, (1997).
Li, Q. H., Brown, J. B., Huang, H. Y. & Bickel, P. J. Measuring reproducibility of high-throughput experiments. Ann. Appl. Stat. 5, 1752–1779. https://doi.org/10.1214/11-Aoas466 (2011).
Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24–26. https://doi.org/10.1038/nbt.1754 (2011).
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.nature.com/articles/s41598-024-80266-9